Approval · Notice of Compliance 154 · 2004
RIVA-RANITIDINE: Notice of Compliance 154
Issued February 26, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 154
- Date
- February 26, 2004
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New supplier of the drug product and product name change from ranitidine
- Therapeutic class
- Histamine H2-receptor antagonist
- Canadian reference product
- ZANTAC
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIVA-RANITIDINE | 02238579 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB